Degroof Petercam - Societe Pour LInformatique Industrielle (SII) SII - The Group outperforms the sector

Report

Degroof Petercam

Denis Scherrer (IDMidCaps)

SII - The Group outperforms the sector

EBIT before share-based payment up 10% in H1, with margin down by just 0.25pt, a better performance than peers and slightly ahead of our expectationsInternational operations continue to post double-digit growth and an EBIT margin (before share-based payment) of over 12%, thanks in particular to Germany and despite weaker momentum in Poland.In France, SII's momentum is slowing, as is that of all its comparables, but it is still growing organicallyIn Q3, the Group is targeting sales growth of 7-10%, or +2 to +5% on an organic basis according to our estimates, which would still place it at the top end

08/12/2023 1 EN

Underlying

Societe Pour L'Informatique Industrielle

Societe Pour l Informatique Industrielle SA is a France-based company principally engaged in the provision of consultancy services to enterprises in the industrial, financial and service sectors on the implementation of technically complex projects, including technical and industrial systems, telecommunications and networks, e-banking, information systems, systems administration and new information and communication technologies. The Company has two principal activities: the external research and development in data processing and telecommunications, and integration of systems in technical data processing and networks. It offers a range of services, including consulting and studies, development engineering and tests, as well as deployment and maintenance. The Company has such subsidiaries as Rucker Aerospace GmbH, Rucker France and its Dutch subsidiary Silver Aerospace BV, and I+D group in Colombia, among others.

See profile

FR0000074122 Euronext Paris France

Provider

Degroof Petercam

We are an investment house with Belgian roots founded on more than 150 years of trust.

As a private company owned by long-term committed shareholders, we are independent. Naturally and structurally. Our experts have the knowledge to think and act without bias, and to make decisions that benefit our clients. Today and tomorrow.

See profile

Analysts

Denis Scherrer (IDMidCaps)

Other Reports on these Companies

GlobeNewsWire

SII : COMMUNIQUÉ RELATIF À LA MISE EN ŒUVRE DU RETRAIT OBLIGATOIRE VISANT LES ACTIONS DE LA SOCIÉTÉ SII CONSÉCUTIVEMENT À L’OFFRE PUBLIQUE D’ACHAT SIMPLIFIÉE INITIÉE PAR LA SOCIÉTE SII GOES ON

SII : COMMUNIQUÉ RELATIF À LA MISE EN ŒUVRE DU RETRAIT OBLIGATOIRE VISANT LES ACTIONS DE LA SOCIÉTÉ SII CONSÉCUTIVEMENT À L’OFFRE PUBLIQUE D’ACHAT SIMPLIFIÉE INITIÉE PAR LA SOCIÉTE SII GOES ON Agissant de concert avec Monsieur Bernard Huvé, Madame Alexia Slape, Monsieur Arnaud Huvé, Monsieur Alban Huvé, Madame Christiane Guillebaut, Monsieur Eric Matteucci, Monsieur Antoine Leclercq, Monsieur François Goalabré, Monsieur Charles Mauclair, Monsieur Didier Bonnet et BTO Sanok S.à r.l. MONTANT DE L’INDEMNISATION : 70,00 euros par action Société pour l’Informatique Industrielle ...

February 29, 2024 February 29, 2024 1 EN

GlobeNewsWire

SII : Succès de l’offre publique d’achat simplifiée visant les actions SII - SII Goes On et les membres du concert franchissent les seuils de 90% du capital et des droits de votes de SII permettant la mise en œuvre d’un retrait obligatoire.

SII : Succès de l’offre publique d’achat simplifiée visant les actions SII - SII Goes On et les membres du concert franchissent les seuils de 90% du capital et des droits de votes de SII permettant la mise en œuvre d’un retrait obligatoire. Paris, le 26 février 2024 Succès de l’offre publique d’achat simplifiée visant les actions SII SII Goes On et les membres du concert franchissent les seuils de 90% du capital et des droits de votes de SII permettant la mise en œuvre d’un retrait obligatoire. Paris, le 26 février 2024 – Société pour l’Informatique Industrielle (ISIN...

February 26, 2024 February 26, 2024 1 EN

SmartInsider

SII: 4 directors

Four Directors at SII sold after exercising options/sold 62,657 shares at 70.000EUR. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules....

Free Trial

February 24, 2024 February 24, 2024 1 EN

(Sponsored) Whitestone Group - H1-24: Very active first half and ready to invest

Whitestone's NAV almost tripled in size over H1 from EUR 34.4m to EUR 99.7m at June 30.The majority of the immense growth is thanks to two capital raises with in total EUR 59.7m raised.The remainder of the growth comes from the solid performance in the portfolio (+EUR 6m).The company still has more than EUR 20m in cash available to deploy, even after its most recent investment in Lambda X Ophtalmics.We estimate today's NAV at EUR 14.5 p/s implying a discount of 16.5%. Our TP moves to EUR 13.4 (was EUR 13.9) and we reiterate our Hold rating.

October 28, 2024 October 28, 2024 1 EN

David Seynnaeve ... (+2)

David Seynnaeve
PhD

(Sponsored) Oncodesign Precision Medicine - Final Ph1 results of RIPK2 inhibitor OPM-101 paving the way for Ph1b/2a launch

*OPM reported the final results of its Ph1 study with RIPK2 inhibitor ‘OPM-101'. Ph1b/2a expected to launch early 2025.*While results look highly encouraging, with strong safety data and no cardiac toxicity, we await clarity on the Ph1b/2a trial protocol and pursued indication.*Our rNPV-based valuation takes into account estimates related to OPM-101 and OPM-201 and does not factor in the potential dilutive impact of any future capital raises. Discovery/preclinical-stage programs are considered upside for the time being. We recommend to Buy the stock considering the attractive 66% upside a...

October 23, 2024 October 23, 2024 1 EN

Luuk Van Beek

Luuk Van Beek

(Sponsored) Cabka - Encouraging sales trend in Q3

Q3-24 sales increased 8% to EUR 42.4m, showing an encouraging sequential trendManagement reiterates its guidance for EUR 180-185m in revenues and a 13-15% EBITDA margin in 2024We will fine-tune our estimates and reiterate our Buy and EUR 4.60 TP

October 21, 2024 October 21, 2024 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN